AzTrials
AzTrials

MalnutritionNCT05682781

Nutrition Intervention in Older Adults at Risk of Malnutrition

A study testing Oral Nutritional Supplement and Dietary Counseling in people with Malnutrition, run by Abbott Nutrition at 2 sites in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Thailand is one of the fastest aging countries and older adults are at greater risk of having inadequate nutrient intake and malnutrition (undernutrition). In the community setting, malnutrition has been linked to low muscle mass, sarcopenia, increased incidence of disability and functional impairments. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Malnutrition
What is being tested?
Oral Nutritional Supplement and Dietary Counseling
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
196 participants
Where
2 sitesThailand
Study dates
9 Mar 2023to 2 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female participant aged ≥60 years at risk of undernutrition.
  • Community-dweller.
  • Participant is community ambulant.
  • Participant does not have any chronic disease(s) or has stable chronic disease(s) at study entry.
  • Participant voluntarily signed and dated on an IRB approved informed consent form (ICF) and provided authorization prior to study participation.
  • Participant is able to communicate and follow instructions.
Show all 9Show fewer
  • Participant is able to consume food and beverages orally.
  • Participant is willing to refrain from taking non-study oral nutritional supplements.
  • Participant is able and willing to follow study procedures and record data in diary and complete forms or assessments as needed.

Who cannot join

  • Participant diagnosed with type 1 or type 2 diabetes.
  • Participant has active infectious disease.
  • Participant has been diagnosed with severe gastrointestinal disorders.
  • Participant has been diagnosed with advanced renal disease or end stage organ or pre-terminal diseases or acute myocardial infarction within the last 30 days from the baseline visit.
  • Participant has active malignancy within the last five years, or is in current treatment for malignancy.
  • Participant has any condition, which in the investigator's opinion, makes him or her unsuitable for inclusion in the study.
Show all 12Show fewer
  • Participant is taking part in another study that has not been approved as a concomitant study.
  • Participant has disorder or other conditions, that may interfere with study product consumption or compliance with study protocol procedures.
  • Participant has been diagnosed or known to be allergic or intolerant to milk products.
  • Participant has continuous oral nutritional supplement usage for 30 days prior to the baseline visit.
  • Participant has been taking herbals, dietary supplements, or medications during the past 30 days prior to the baseline visit that could profoundly affect body weight or appetite.
  • Participant has clinically significant ascites, pleural effusion, edema, or dehydration

Trial locations and contacts

2 sites in 1 country.

Thailand2 sites
  • Faculty of Medicine Siriraj Hospital, Mahidol University

    Bangkoknoi, Bangkok, 10700

  • The Department of Internal Medicine, Faculty of Medicine, Thammasat University

    Pathum Thani, 12120

Other trials in Thailand

About this study

Official title: Effects of Oral Nutritional Supplement With Dietary Counseling in Community Dwelling Older Adults at Risk of Malnutrition

Thailand is one of the fastest aging countries and older adults are at greater risk of having inadequate nutrient intake and malnutrition (undernutrition). In the community setting, malnutrition has been linked to low muscle mass, sarcopenia, increased incidence of disability and functional impairments. The objective of this prospective, multicenter, randomized controlled, open-label, parallel-design study is to determine the effects of an oral nutritional supplement with dietary counseling on body weight, in comparison with dietary counseling alone, in community dwelling older adults at risk of malnutrition.

Conditions
Malnutrition
Being tested
Oral Nutritional Supplement, Dietary Counseling
Medical subject headings
Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral Nutritional SupplementDietary supplement

    Oral Nutritional Supplement

  • Dietary CounselingOther

    Dietary Counseling

Study groups in NCT05682781
Study groupRoleWhat they receive
Dietary CounselingActive comparatorNot described
Receives: Other: Dietary Counseling
Dietary Counseling + Oral Nutritional SupplementExperimentalNot described
Receives: Dietary Supplement: Oral Nutritional Supplement; Other: Dietary Counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in body weight

    Measured in kg

    Measured: Baseline to 60 days

Secondary outcomes (6)
  1. Malnutrition risk

    Malnutrition Universal Screening Tool is a widely used screening tool for malnutrition. It classifies participants into one of three nutrition status categories: low risk/score = 0, medium risk/score = 1, and high risk/score ≥ 2. Minimum value = 0, Maximum value = 6. Higher score indicates worse outcome, i.e., increased risk of malnutrition.

    Measured: Baseline, Study Day 30 and Study Day 60

  2. Body mass index (BMI)

    Weight (kg)/Height (m)2

    Measured: Baseline, Study Day 30 and Study Day 60

  3. Mid-upper arm circumference

    Measured in cm

    Measured: Baseline, Study Day 30 and Study Day 60

  4. Change in body weight

    Measured in kg

    Measured: Baseline and Study Day 30

  5. Energy intake

    24-Hour Dietary Recall: Researcher-led interview on food and drink intake the previous day. Nutrient analysis will be performed using a dietary analysis program.

    Measured: Baseline, Study Day 30 and Study Day 60

  6. Nutrient intake

    24-Hour Dietary Recall: Researcher-led interview on food and drink intake the previous day. Nutrient analysis will be performed using a dietary analysis program.

    Measured: Baseline, Study Day 30 and Study Day 60

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2023
  2. Study start9 Mar 2023
  3. Primary completion29 Feb 2024
  4. Study completion2 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
196 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05682781
Sponsor's protocol ID
BL64
Status last verified
Jul 2024
First submitted
4 Jan 2023
Last updated
1 Aug 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Oral Nutritional Supplement and Dietary Counseling in people with Malnutrition, run by Abbott Nutrition at 2 sites in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in body weight (time frame: Baseline to 60 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in